Company Filing History:
1 out of 832,843 Years Active: 1998
Title: The Innovations of Roland Grunow
Introduction
Roland Grunow is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of human monoclonal antibodies. His work has implications for the treatment of human immunodeficiency virus type 1 (HIV-1).
Latest Patents
Grunow holds a patent for "Human monoclonal anti-HIV-I-antibodies." This invention is directed to human monoclonal antibodies that are specific for the gp41 envelope protein of HIV-1. The patent specifically discloses human monoclonal antibodies produced by cell lines 3D6, 24G3, and 25C2, each with their respective ECACC Accession Numbers.
Career Highlights
Throughout his career, Grunow has focused on innovative solutions in the field of immunology. His research has contributed to a better understanding of HIV-1 and the development of potential therapeutic options.
Collaborations
Grunow has collaborated with esteemed colleagues such as Hermann W Katinger and Ruediger Von Baehr. These partnerships have enhanced the scope and impact of his research.
Conclusion
Roland Grunow's work in developing human monoclonal antibodies represents a significant advancement in the fight against HIV-1. His contributions continue to influence the field of biotechnology and offer hope for future treatments.